NewsBeat: Microbicide Reduces Women's HIV Risk in Large-Scale Trial

By Lisa Rossi

Two large clinical trials have found that a microbicide prevention method can safely help reduce new HIV infections in women.

Results of the ASPIRE trial, which enrolled more than 2,600 women in Africa, were announced today at the Conference on Retroviruses and Opportunistic Infections in Boston. The results also will be published online in the New England Journal of Medicine.

CBS News: Air Pollution Takes a Deadly Toll

By Brian Mastroianni

The numbers are sobering -- more than 5.5 million people die prematurely each year as the result of household and outdoor air pollution, according to new research presented Friday at the 2016 annual meeting of the American Association for the Advancement of Science (AAAS).

What areas are most at risk? The study found more than half of these deaths occur in China and India, two of the world's fastest-growing economies.

KOMO: Local Research Could Cure Zika Virus and the Common Cold

By Molly Shen

SEATTLE -- On the heels of the World Health Organization declaring a public health emergency related to the Zika virus, local scientists said they are already working on a cure. And if they're able to treat Zika, it could also mean a cure for viruses ranging from West Nile to Ebola, to the common cold.

Scientists at biotech company Kineta and the University of Washington are developing the compound. Just like antibiotics treat bacterial infections, their antiviral drug would fend off a range of viruses.

Pages